drugset / Trial / NCT00372996
Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
To test the efficacy of CP-751,871 combined with exemestane in the treatment of postmenopausal patients with hormone positive advanced breast cancer
Timeline
- Start
- 2007-02
- Primary completion
- 2012-09
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Exemestane | Small molecule | 25 mg | Oral |
| Subject | Figitumumab | Monoclonal antibody | 20 mg/kg | Intravenous |
| Background | Fulvestrant | Small molecule | — | — |